{
  "documentInfo": {
    "title": "TUH-Inc. Empiric Antimicrobial Therapy Recommendations for Common Infections in Hospitalized Adults",
    "system": "TUH-Inc.",
    "versionDate": "2025-04-02",
    "sourceFile": "ATTCHMENT A_Inpatient Empiric antimicrobial Recommendations for common infections_ver 2025-04-02_shared with ED.docx"
  },
  "infections": [
    {
      "id": "skin_soft_tissue_infection",
      "name": "Skin and Soft Tissue Infection (SSTI)",
      "diagnostics": null,
      "pathways": [
        {
          "label": "Non-purulent (non-severe) cellulitis",
          "eligibilityCriteria": {
            "clinicalState": ["stable", "non-purulent", "no_systemic_symptoms"]
          },
          "duration": {"minDays": 5, "maxDays": 7},
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "cephalexin"}]},
                {"rank": 2, "primaryDrugs": [{"name": "cefazolin"}]}
              ]
            },
            {
              "allergyProfile": ["pcn_mild_rash"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "trimethoprim-sulfamethoxazole"}]},
                {"rank": 2, "primaryDrugs": [{"name": "cefazolin"}]}
              ]
            },
            {
              "allergyProfile": ["pcn_severe_anaphylaxis"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "trimethoprim-sulfamethoxazole"}]},
                {"rank": 2, "primaryDrugs": [{"name": "vancomycin"}]}
              ]
            }
          ]
        },
        {
          "label": "Purulent (non-severe) cellulitis",
          "eligibilityCriteria": {
            "clinicalState": ["stable", "purulent", "no_systemic_symptoms"]
          },
          "duration": {"minDays": 5, "maxDays": 7, "notes": ["If I&D of abscess is performed, count 5-7 days from source control."]},
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none", "pcn_mild_rash", "pcn_severe_anaphylaxis"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "trimethoprim-sulfamethoxazole"}]},
                {"rank": 2, "primaryDrugs": [{"name": "doxycycline"}]},
                {"rank": 3, "primaryDrugs": [{"name": "vancomycin"}]}
              ]
            }
          ]
        },
        {
          "label": "Injection-related cellulitis and/or xylazine related wounds (non-severe)",
          "eligibilityCriteria": {
            "clinicalState": ["stable", "no_systemic_symptoms"],
            "riskFlags": ["injection_drug_use"]
          },
          "duration": {"minDays": 5, "maxDays": 7, "notes": ["If I&D of abscess is performed, count 5-7 days from source control."]},
          "procedureRecommendations": ["In stable patients, hold OFF on antibiotics until wound care and thorough wound examination is performed."],
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "amoxicillin", "variants": [{"label": "1gm q12h PO"}]}, {"name": "doxycycline"}]},
                {"rank": 2, "primaryDrugs": [{"name": "trimethoprim-sulfamethoxazole"}]},
                {"rank": 3, "primaryDrugs": [{"name": "vancomycin"}]},
                {"rank": 4, "primaryDrugs": [{"name": "daptomycin"}]}
              ]
            },
            {
              "allergyProfile": ["pcn_mild_rash", "pcn_severe_anaphylaxis"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "trimethoprim-sulfamethoxazole"}]},
                {"rank": 2, "primaryDrugs": [{"name": "vancomycin"}]},
                {"rank": 3, "primaryDrugs": [{"name": "daptomycin"}]}
              ]
            }
          ]
        },
        {
          "label": "Severe sepsis patient with SSTI (non-necrotizing)",
          "eligibilityCriteria": {
            "clinicalState": ["severe_sepsis", "septic_shock"],
            "riskFlags": ["non_necrotizing"]
          },
          "duration": {"notes": ["Duration depends on the causative pathogen and clinical scenario."]},
          "consults": ["Please consult infectious diseases if assistance needed."],
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none", "pcn_mild_rash"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "ceftriaxone"}, {"name": "vancomycin"}],
                  "notes": [
                    "Consider Cefepime if immunocompromised host.",
                    "For vancomycin allergy, substitute with Linezolid or Daptomycin."
                  ]
                }
              ]
            },
            {
              "allergyProfile": ["pcn_severe_anaphylaxis"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "vancomycin"}, {"name": "aztreonam"}],
                  "notes": ["For vancomycin allergy, substitute with Linezolid or Daptomycin."]
                }
              ]
            }
          ]
        },
        {
          "label": "Necrotizing SSTI (NSTI)",
          "eligibilityCriteria": {
            "clinicalState": ["necrotizing_infection"]
          },
          "duration": {"notes": ["Duration depends on the causative pathogen and clinical scenario."]},
          "procedureRecommendations": ["Recommend early general surgery consultation."],
          "consults": ["Recommend ID consult."],
          "treatmentRecommendations": [
            {
              "allergyProfile": ["none"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "piperacillin-tazobactam"}, {"name": "linezolid"}]},
                {"rank": 2, "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "linezolid"}]},
                {"rank": 3, "primaryDrugs": [{"name": "piperacillin-tazobactam"}, {"name": "clindamycin"}, {"name": "vancomycin"}]},
                {"rank": 4, "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "vancomycin"}, {"name": "clindamycin"}]}
              ]
            },
            {
              "allergyProfile": ["pcn_mild_rash"],
              "regimens": [
                {"rank": 1, "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "linezolid"}]},
                {"rank": 2, "primaryDrugs": [{"name": "cefepime"}, {"name": "metronidazole"}, {"name": "vancomycin"}, {"name": "clindamycin"}]}
              ]
            },
            {
              "allergyProfile": ["pcn_severe_anaphylaxis"],
              "regimens": [
                {
                  "rank": 1,
                  "primaryDrugs": [{"name": "aztreonam"}, {"name": "linezolid"}, {"name": "metronidazole"}],
                  "notes": [
                    "Consider meropenem in place of aztreonam/metronidazole if critically ill (i.e. ICU admission).",
                    "If patient has a history of SJS/DRESS: use (Linezolid) OR (Vancomycin + Clindamycin) AND CONSULT INFECTIOUS DISEASES for guidance on gram negative coverage."
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ]
}